ArchPoint Investors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.93M | Hold |
14,095
| – | – | 1.65% | 16 |
|
|
2025
Q4 | $8.17M | Hold |
14,095
| – | – | 1.94% | 13 |
|
|
2025
Q3 | $6.84M | Buy |
14,095
+45
| +0.3% | +$20.9K | 1.88% | 13 |
|
|
2025
Q2 | $5.7M | Hold |
14,050
| – | – | 1.68% | 14 |
|
|
2025
Q1 | $7M | Sell |
14,050
-80
| -0.6% | -$43.3K | 2.3% | 12 |
|
|
2024
Q4 | $7.36M | Hold |
14,130
| – | – | 2.42% | 12 |
|
|
2024
Q3 | $8.75M | Sell |
14,130
-100
| -0.7% | -$59.2K | 2.92% | 11 |
|
|
2024
Q2 | $7.87M | Hold |
14,230
| – | – | 2.96% | 11 |
|
|
2024
Q1 | $8.28M | Hold |
14,230
| – | – | 3.45% | 10 |
|
|
2023
Q4 | $7.56M | Sell |
14,230
-450
| -3% | -$218K | 3.15% | 7 |
|
|
2023
Q3 | $7.44M | Hold |
14,680
| – | – | 2.84% | 11 |
|
|
2023
Q2 | $7.66M | Hold |
14,680
| – | – | 2.96% | 10 |
|
|
2023
Q1 | $8.47M | Hold |
14,680
| – | – | 3.68% | 6 |
|
|
2022
Q4 | $8.09M | Hold |
14,680
| – | – | 3.83% | 7 |
|
|
2022
Q3 | $7.45M | Hold |
14,680
| – | – | 3.04% | 8 |
|
|
2022
Q2 | $7.98M | Hold |
14,680
| – | – | 3.16% | 6 |
|
|
2022
Q1 | $8.68M | Hold |
14,680
| – | – | 2.99% | 8 |
|
|
2021
Q4 | $9.8M | Sell |
14,680
-837
| -5% | -$523K | 2.91% | 9 |
|
|
2021
Q3 | $8.87M | Buy |
15,517
+1,854
| +14% | +$1.02M | 2.66% | 8 |
|
|
2021
Q2 | $6.9M | Sell |
13,663
-1,071
| -7% | -$505K | 2.34% | 9 |
|
|
2021
Q1 | $6.73M | Hold |
14,734
| – | – | 1.91% | 12 |
|
|
2020
Q4 | $6.87M | Sell |
14,734
-160
| -1% | -$75K | 1.9% | 11 |
|
|
2020
Q3 | $6.58M | Hold |
14,894
| – | – | 2.1% | 11 |
|
|
2020
Q2 | $5.4M | Sell |
14,894
-13,779
| -48% | -$4.62M | 1.73% | 14 |
|
|
2020
Q1 | $4.74M | Buy |
28,673
+13,489
| +89% | +$4.25M | 1.87% | 11 |
|
|
2019
Q4 | $4.94M | Hold |
15,184
| – | – | 1.51% | 16 |
|
|
2019
Q3 | $4.42M | Sell |
15,184
-750
| -5% | -$215K | 1.5% | 15 |
|
|
2019
Q2 | $4.68M | Hold |
15,934
| – | – | 1.48% | 14 |
|
|
2019
Q1 | $4.36M | Hold |
15,934
| – | – | 1.3% | 15 |
|
|
2018
Q4 | $3.57M | Hold |
15,934
| – | – | 1.24% | 16 |
|
|
2018
Q3 | $3.89M | Sell |
15,934
-8,000
| -33% | -$1.84M | 1.06% | 20 |
|
|
2018
Q2 | $4.96M | Buy |
23,934
+750
| +3% | +$159K | 1.43% | 14 |
|
|
2018
Q1 | $4.79M | Buy |
23,184
+51
| +0.2% | +$10.7K | 1.41% | 15 |
|
|
2017
Q4 | $4.4M | Sell |
23,133
-1
| -0% | -$192 | 1.37% | 16 |
|
|
2017
Q3 | $4.38M | Hold |
23,134
| – | – | 1.4% | 15 |
|
|
2017
Q2 | $4.04M | Sell |
23,134
-2,321
| -9% | -$390K | 1.29% | 15 |
|
|
2017
Q1 | $3.91M | Sell |
25,455
-3,000
| -11% | -$459K | 1.47% | 14 |
|
|
2016
Q4 | $4.01M | Hold |
28,455
| – | – | 2.36% | 12 |
|
|
2016
Q3 | $4.53M | Hold |
28,455
| – | – | 2.59% | 11 |
|
|
2016
Q2 | $4.21M | Sell |
28,455
-1,075
| -4% | -$159K | 2.4% | 13 |
|
|
2016
Q1 | $4.18M | Buy |
29,530
+1,000
| +4% | +$134K | 2.29% | 10 |
|
|
2015
Q4 | $4.05M | Sell |
28,530
-75
| -0.3% | -$10K | 2.85% | 8 |
|
|
2015
Q3 | $3.5M | Hold |
28,605
| – | – | 2.43% | 9 |
|
|
2015
Q2 | $3.71M | Sell |
28,605
-220
| -0.8% | -$28.7K | 2.32% | 10 |
|
|
2015
Q1 | $3.87M | Sell |
28,825
-10,000
| -26% | -$1.29M | 2.64% | 7 |
|
|
2014
Q4 | $4.86M | Hold |
38,825
| – | – | 3.6% | 3 |
|
|
2014
Q3 | $4.72M | Hold |
38,825
| – | – | 4% | 2 |
|
|
2014
Q2 | $4.58M | Sell |
38,825
-400
| -1% | -$47.1K | 3.86% | 2 |
|
|
2014
Q1 | $4.72M | Buy |
39,225
+400
| +1% | +$47.6K | 4.25% | 2 |
|
|
2013
Q4 | $4.32M | Buy |
38,825
+265
| +0.7% | +$26.4K | 3.93% | 3 |
|
|
2013
Q3 | $3.55M | Buy |
38,560
+420
| +1% | +$38K | 3.91% | 3 |
|
|
2013
Q2 | $3.23M | Buy |
+38,140
| New | +$3.17M | 3.81% | 3 |
|
Other funds holding TMO
VCM
ArchPoint Investors's TMO Position: Q1 2026 in Review
ArchPoint Investors held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 14,095 shares worth $6.93M. The position accounts for 1.65% of the portfolio, ranked #16.
ArchPoint Investors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.8M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- ArchPoint Investors held 14,095 shares of Thermo Fisher Scientific worth $6.93M as of Q1 2026.
- ArchPoint Investors left its Thermo Fisher Scientific share count unchanged in Q1 2026.
- Thermo Fisher Scientific made up 1.65% of ArchPoint Investors's portfolio in Q1 2026, its #16 holding.
- ArchPoint Investors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- ArchPoint Investors's Thermo Fisher Scientific position peaked at $9.8M in Q4 2021.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on ArchPoint Investors's 13F filing for Q1 2026, filed 14 May 2026.